Introduction
Gastric cancer (GC) is one of the most common cause of cancer deaths worldwide diagnosed more often in men than women. The increased incidence of this tumor in men cannot be explained by any of known gender differences or environmental factors, therefore the growth of GC may be regulated by sex steroid hormones [1] . In fact, several studies demonstrated the protective role of estrogens, especially 17β-estradiol (E2) in the etiology of GC and furthermore, the presence of both, estrogen and androgen receptors has been detected in normal and cancerous gastric mucosa [1] . Findings focused on sex steroid biology revealed that large amounts of estrogens and androgens are produced locally in various peripheral tissues in postmenopausal women and older men [2] . Since synthesis of estrogens and androgens has been demonstrated in rat parietal cells it was suggested that the certain amounts of steroid hormones can be also synthesized in gastric mucosa [3, 4] . Relevant evidence confi rming this statement came from studies concerned the expression of genes encoding steroidogenic enzymes in gastric tissues, which were responsible for in situ conversion of biologically inactive precursors into active steroids. Their deregulated expression has been shown in various neoplasm including GC [5] [6] [7] [8] [9] [10] [11] [12] . These abnormalities can be associated with the formation of abnormal amounts of steroid hormones and thus, affect gastric carcinogenesis [9, 13] .
Intracrinology
Close to 100% of active steroids in postmenopausal women and approximately 50% of androgens in adult men are produced locally in peripheral tissues [2] . However, in contrary to classical endocrine manner, the large amount of estrogens and androgens synthesized in peripheral tissues are not release into the general circulation but act locally, in the same cell where synthesis took place. To describe this local action of steroid hormones, in 1988 Labrie et al. coined new term -"intracrinology" [14] . In this process, circulating dehydroepiandrosterone (DHEA) and estrone (E1) are metabolized to active steroid hormones by specific steroidogenic enzymes in peripheral tissues. Both, DHEA and E1, are mainly present in the blood as biologically inactive DHEA-sulfate (DHEA-S) and E1-sulphate (E1-S). DHEA-S and E1-S exhibit a long half-life, what makes them the most important reservoir of steroid precursors in the intracrine mechanism of steroid synthesis. In target tissues DHEA-S and E1-S are desulfated and then are involved in further steps of steroidogenesis [2, 5] , detailed in Figure 1 .
Expression of genes encoding steroidogenic enzymes in nontumoral and tumoral gastric mucosa To date, the presence of mRNA and protein of numerous genes involved in steroidogenesis was found in nontumoral and tumoral gastric mucosa. Simultaneously, expression of some of these genes was altered in GC mucosa as compared with normal counterparts (Table 1) . It was shown that the expression of steroid sulfatase (STS) at mRNA level was decreased in tumoral gastric tissues as compared with adjacent nontumoral mucosa [12] . Previous studies suggested that STS contributes to the in situ activation of E1 from E1-S in breast cancer and to mild androgen defi ciency, with signifi cantly lower circulating concentrations of DHEA and testosterone in patients with STS defi ciency syndrome [15, 16] . Thus, decreased expression of STS in GC can be associated with an inhibited synthesis of estrogens and androgens due to depletion of available E1 and DHEA. Among 17β-hydroxysteroid dehydrogenases (HSD17Bs) family, mRNA of HSD17B7 as well as mRNA and protein of HSD17B1 were detected in gastric mucosa; however, there was no difference Figure 1 . Steroidogenesis in peripheral tissues. Circulating dehydroepiandrosterone sulfate (DHEA-S) and estrone sulfate (E1-S), are taken up into the cell of peripheral tissues. Then, after the removal of sulfate by steroid sulfatse (STS), DHEA can be converted to 4-androstenedione (4-dione) by 3β-hydroxysteroid dehydrogenase/∆5-4 isomerases (HSD3Bs) type 1 and 2 or to androst-5-ene-3β,17β-diol (5-diol) by the members of the family of 17β-hydroxysteroid dehydrogenases (HSD17Bs), mainly by HSD17B1 and HSD17B5. The both 4-dione and 5-diol can serve as a substrate to testosterone synthesis. Conversion of 4-dione to testosterone is catalyzed mainly by HSD17B5 whereas HSD3B1 and HSD3B2 mediate in metabolism of 5-diol. The most potent androgen, dihydrotestosterone (DHT) is produced from testosterone due to activity of 5α-reductases type 1 and 2. Estrogens are synthesized in so called "sulfatase pathway" and an "aromatase pathway". In the sulfatase pathway E1 is reduced to E2 due to the activity of HSD17B1, HSD17B5 and HSD17B7. In the aromatase pathway, E1 and E2 are synthesized by aromatase from 4-dione and testosterone respectively. Less active forms of androgens and estrogens are mainly produced by HSD17B2 in the expression level of those genes among cancerous and histopathologically unchanged gastric tissues [12, 17] . On the other hand, the synthesis of E2 from E1 through HSD17B1 activity was demonstrated in GC cell lines therefore this enzyme can play a role in E2 synthesis during gastric carcinogenesis [17] . Other studies, detected an immunoreactivity of HSD17B5 in tumoral and nontumoral gastric specimens [9] . More importantly, the mRNA level of HSD17B5 (AKR1C3) was decreased in GC as compared with adjacent normal tissue [11] . Since AKR1C3 participates in the conversion of both, 4-androstenedione to testosterone and Immunoreactivity in 57 of 117 cases of tumoral mucosa and no observed immunoreactivity in normal mucosa [9] E1 to E2, its down-regulation can result in the reduction of intratissue concentration of biologically potent steroids [18] . Furthermore, the presence of HSD17B2 mRNA was confi rmed in different histological types of gastric mucosa. Its decreased expression at both mRNA and protein level has been observed in tumoral gastric specimens as compared with nontumoral counterparts [10, 19] . The role of androgens in GC is unclear; however, some studies suggest that testosterone can induce gastric cancerogenesis [20] . Therefore, down-regulation of HSD17B2 can be associated with increased intracellular concentration of E2 which can be protective, but also with an increased level of testosterone which can be noxious. In fact, an immunoreactivity of 5α-reductases type 1 and 2, which are responsible for the synthesis of DHT, the most biologically potent form of androgens, was reported in gastric carcinoma but not in the non-neoplastic gastric epithelium [9] . Synthesis of androgens in peripheral tissues is also controlled by 3β-hydroxysteroid dehydrogenase/ ∆5-4isomerase type 1 (HSD3B1) . Surprisingly, studies has shown lower mRNA level of HSD3B1 in gastric cancerous mucosa than in normal adjacent mucosa; however, overall mRNA content of this gene was low in both types of gastric tissues [12] . Importantly, androgens can be subsequently aromatized to estrogens by aromatase (CYP19) [2] . It was revealed that CYP19 mRNA level was increased in GC as compared with nontumoral specimens, but similarly to HSD3B1, mRNA content of CYP19 was found to be low in both types of examined tissues [12] . In the other studies, positive immunoreactivity for CYP19 was demonstrated in GC, whereas all nontumoral gastric mucosa specimens were negative for this enzyme [21] . Nevertheless, rat models demonstrated the capability of parietal cells to convert circulating androgens into estrogens with the simultaneous expression of CYP19 mRNA and protein [22] [23] [24] . Moreover, the synthesis of E2 through aromatization of exogenous testosterone was demonstrated in GC cell lines [25] . Thus, expression of CYP19 seems to play some role in estrogen synthesis from androgens in gastric mucosa.
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Conclusion
Several studies confi rmed that genes involved in local steroidogenesis are expressed in normal and cancerous gastric mucosa. Therefore, some amounts of steroid hormones can be synthesized in these tissues. Because the majority of examined genes were found to be down-regulated in GC as compared with nontumoral gastric mucosa, gastric cancerogenesis can be associated with reduced production of steroid hormones in situ. However, the exact role of estrogens and androgens in GC development and progression needs to by further clarifi ed. At that time, above fi ndings could be helpful in therapeutic approaches.
